GSK (GLAXF)
18.46
-0.33 (-1.77%)
At close: Apr 23, 2025, 1:18 PM
-1.77% (1D)
| Bid | 17.8 |
| Market Cap | 74.8B |
| Revenue (ttm) | 31.38B |
| Net Income (ttm) | 2.58B |
| EPS (ttm) | 0.82 |
| PE Ratio (ttm) | 22.51 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 18.79 |
| Volume | 1,037 |
| Avg. Volume (20D) | 2,550 |
| Open | 18.46 |
| Previous Close | 18.79 |
| Day's Range | 18.46 - 18.46 |
| 52-Week Range | 15.54 - 23.00 |
| Beta | 0.30 |
About GLAXF
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medic...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jan 5, 2010
Employees 68,629
Stock Exchange PNK
Ticker Symbol GLAXF
Website https://www.gsk.com